[Correct nomenclature, symptom score, laboratory values and ultrasound. Your tools for diagnosis of benign prostatic hyperplasia syndrome].
Advances in our knowledge of prostatic disease made it necessary to amend our original terminology. This now takes account of the fact that the syndrome may differ from one patient to another, and forms the basis for the diagnostic approach. In particular, its intention is to show that not every patient with LUTS (lower urinary tract symptoms) has "BPH". The diagnostic approach to BP(H) (new terminology) encompasses--apart from the case history (symptom score IPSS) and physical examination--a laboratory work-up (among other things to exclude a bacterial infection, malignant tumour and renal insufficiency), uroflowmetry and the determination of residual urine. In proven BP(H)S ultrasonography of the kidneys, bladder and prostate (size) is mandatory. Conservative treatment, whatever form it takes, is not indicated until the diagnostic measures have been completed.
Menninger
M
M
Urologische Klinik und Poliklinik, Klinikum Grosshadern der LMU München.
Hofstetter
A
A
D014408:Biomarkers, Tumor / Q000097:blood*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000145:classification / Q000175:diagnosis*; D009626:Terminology as Topic; D014563:Urodynamics
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen